Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?

Intern Emerg Med. 2022 Jan;17(1):295-297. doi: 10.1007/s11739-021-02778-w. Epub 2021 Jun 7.

Authors

Federico Pasin¹, Alberto Calabrese², Laura Pelagatti³

Affiliations

¹ Internal Medicine Unit, ASST Cremona, Oglio-Po Hospital, Viale Concordia 1, 26100, Cremona, Italy. [email protected].
² Intensive Care Unit, AOUPR, Parma, Italy.
³ Internal Medicine Unit, ASST Cremona, Oglio-Po Hospital, Viale Concordia 1, 26100, Cremona, Italy.

No abstract available

Keywords: COVID-19; Immune thrombocytopenic purpura; Thrombocytopenia; Vaccine; mRNA.

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Purpura, Thrombocytopenic, Idiopathic* / etiology
Purpura, Thrombotic Thrombocytopenic*
SARS-CoV-2
Vaccines, Synthetic
mRNA Vaccines

Substances

COVID-19 Vaccines
Vaccines, Synthetic
mRNA Vaccines